Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Clinical trial NCT06815003 · RECRUITING

Trial details

NCT number: NCT06815003
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Graft Versus Host Disease Myelodysplastic Syndrome Myeloproliferative Neoplasm

Start date: 2025-04-18
Primary completion: 2028-10-15
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.